Diagnostic Testing & Technology Report
March 2010
Special Focus: Personalized Medicine: Pfizer and Qiagen to Develop Companion Diagnostic for Brain Tumor Patients
Pfizer (New York) and Qiagen subsidiary DxS (Manchester, England) have entered into an agreement to develop a companion diagnostic test kit for an immunotherapy vaccine that Pfizer is developing for the treatment of glioblastoma multiforme (GBM). Financial terms of the deal were not disclosed.
Login | Subscribe
March 2010 - Table of Contents
Diagnostic Testing & Technology Report is part of...
Focus Areas |
Product Group |
 G2 Reports Medical Lab Management |
Newsletters |